ECM1 and neoplasm: Osteoblasts in the BM microenvironment secrete ECM1, which interacts with the ENO1 receptor on the surface of PCa cells and induces ENO1 phosphorylation at the Y189 site, further activating the downstream MAPK signaling pathway, promoting tumor proliferation, and contributing to treatment resistance (Figure9).